How can attrition rates be reduced in cancer drug discovery?

Moreno, Lucas

How can attrition rates be reduced in cancer drug discovery? [electronic resource] - Expert opinion on drug discovery Apr 2013 - 363-8 p. digital

Publication Type: Editorial; Research Support, Non-U.S. Gov't

1746-045X

10.1517/17460441.2013.768984 doi


Antineoplastic Agents--economics
Clinical Trials as Topic
Drug Approval--economics
Drug Discovery--economics
Drug Industry--economics
Humans
Neoplasms--drug therapy